Cargando…
SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses
In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the globe, even in countries where vaccination programs have been strongly implemented. In these regions in 2021, a reduction in the number of hospitalizations and deaths compared to 2020 was observed. This...
Autores principales: | Fiorino, Sirio, Carusi, Andrea, Hong, Wandong, Cernuschi, Paolo, Gallo, Claudio Giuseppe, Ferrara, Emanuele, Maloberti, Thais, Visani, Michela, Lari, Federico, de Biase, Dario, Zippi, Maddalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIMS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834075/ https://www.ncbi.nlm.nih.gov/pubmed/36694588 http://dx.doi.org/10.3934/microbiol.2022029 |
Ejemplares similares
-
Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905) -
The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013) -
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)